CHI3L1 and in situ carcinoma: By applying a mass spectrometry-based proteomic approach, CHI3L1 was identified as one of the most differentially abundant proteins in the cerebrospinal fluid (CSF) between CIS patients who converted to MS and those who remained as CIS.